RNF181 and coronary artery disorder: The RNF181 immunostained area in both heart toxicity models showed a decrease of RNF181 protein expression appearing in areas of CAD heart compared with the control heart tissue, suggesting that, at the protein level, the downregulation of RNF181 may be correlated with CAD progression (Figure 3F).